Medical Hypotheses
Volume 58, Issue 1 , Pages 28-33, January 2002

Weight-loss drugs and supplements: are there safer alternatives?

MAK Wood Inc, Grafton, Wisconsin, USA

Received 30 April 2001; accepted 5 July 2001.

Abstract 

Obesity is a major cause of health complaints in western developed countries. Problems ranging from apnea to joint pain have been associated with excess weight. Many factors have been attributed to the epidemic of obesity including sedentary lifestyle, high-fat diets and consumption of large amounts of processed foods. Pharmacies and health-food store shelves abound with a vast selection of products promoted for weight-loss. Some of these have made headlines recently for the damaging effect they have on such things as cardiac valvular function. Unfortunately, others will probably follow and original data is presented on potentially dangerous natural products. Alternatives are presented and discussed below. These natural alternatives include such things as digestive enzyme inhibitors (e.g. L-arabinose, hibiscus tea, marine algae, Nomame Herba, etc), anorexics (e.g. monoterpenes such as d-limonene and perillyl alcohol), glucose-uptake inhibitors (e.g. phlorizin), and probiotics as adjuvants. These all-natural products are presented as some possible alternatives to those that could be potentially lethal and are not meant as the only options.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence to: Mark A. Brudnak PhD ND, VP Technology, MAK Wood Inc, 1235 Dakota Drive, Units E–F, Grafton, WI 53024-9429, USA. E-mail: makwood@earthlink.net

PII: S0306-9877(01)91444-6

doi:10.1054/mehy.2001.1444

Medical Hypotheses
Volume 58, Issue 1 , Pages 28-33, January 2002